Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial-Reference-Cited by-同舟云学术

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

Published:2021-04-01 Issue:4 Volume:178 Page:352-362
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Dwyer Jennifer B.¹,Landeros-Weisenberger Angeli¹,Johnson Jessica A.¹,Londono Tobon Amalia¹,Flores José M.¹,Nasir Madeeha¹,Couloures Kevin¹,Sanacora Gerard¹,Bloch Michael H.¹

Affiliation:

1. Yale Child Study Center (Dwyer, Landeros-Weisenberger, Johnson, Londono Tobon, Flores, Nasir, Bloch), Department of Radiology and Biomedical Imaging (Dwyer), and Department of Psychiatry (Londono Tobon, Flores, Sanacora, Bloch), Yale School of Medicine, New Haven, Conn.; Department of Pediatrics, Stanford University, Stanford, Calif. (Couloures).

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventional approaches to treatment resistant depression (DTR) in children and adolescents: A systematic review and meta-analysis;Journal of Affective Disorders;2024-12

2. Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review;Pharmacology Biochemistry and Behavior;2024-09

3. Empowering understanding: navigating consent to ketamine treatment in adolescent mental health;Frontiers in Psychiatry;2024-08-13

4. Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders;Behavioural Brain Research;2024-08

5. Major challenges in youth psychopathology: treatment-resistant depression. A narrative review;Frontiers in Psychiatry;2024-07-11